The COVID-19 pandemic: Are our dermatological patients on immunomodulating medication at high-risk?

Carsten Sauer Mikkelsen, Kristian Bakke Arvesen, Luit Penninga, Peter Bjerring

Research output: Contribution to journal › Journal article › Communication

Keywords

@article{f4b65b34db6449ea87d736cf773906fc,

title = "The COVID-19 pandemic: Are our dermatological patients on immunomodulating medication at high-risk?",

keywords = "covid-19, dermatology, immunomodulating medication",

author = "Mikkelsen, {Carsten Sauer} and Arvesen, {Kristian Bakke} and Luit Penninga and Peter Bjerring",

year = "2020",

month = apr,

language = "English",

journal = "Best Practice Nordic",

}

TY - JOUR

T1 - The COVID-19 pandemic

T2 - Are our dermatological patients on immunomodulating medication at high-risk?

AU - Mikkelsen, Carsten Sauer

AU - Arvesen, Kristian Bakke

AU - Penninga, Luit

AU - Bjerring, Peter

PY - 2020/4

Y1 - 2020/4

KW - covid-19

KW - dermatology

KW - immunomodulating medication

M3 - Journal article

JO - Best Practice Nordic

JF - Best Practice Nordic

ER -